|
Jan 9
|
AcelRx Announces Rebranding With Name Change to Talphera, Inc.
|
|
Nov 8
|
AcelRx Reports Third Quarter 2023 Financial Results and Provides Corporate Update
|
|
Nov 7
|
AcelRx to Host KOL Panel Discussion on Current Anticoagulant Use in Dialysis and the Upcoming Niyad™ Clinical Study
|
|
Jul 18
|
AcelRx Pharmaceuticals Announces $10 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
|
|
May 3
|
AcelRx Pharmaceuticals (ACRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
|
Apr 27
|
AcelRx to Host First Quarter 2023 Financial Results Call and Webcast on May 10, 2023
|